Rare diseases
Investigational molecules
Locations
9 Avenue Charles De Gaulle, 92100 Boulogne-Billancourt, France
Hopital Ambroise Pare in Boulogne-Billancourt, France specialises in clinical trials of conditions such as Non-small cell lung cancer, Non-small cell lung cancer stage IV, Malignant melanoma, Non-small cell lung cancer metastatic, and other specialisations. This site conducts important research.
The Pain Assessment and Treatment Centre at Hopital Ambroise Pare is actively exploring therapies for inflammatory joint conditions, with a focus on improving function and reducing pain for patients with axial spondyloarthritis.
Ongoing research aims to provide clearer treatment pathways and enhance quality of life for individuals living with musculoskeletal disorders.
Clinical investigations at the centre address a range of cancers, including non‑small cell lung cancer, melanoma, and cutaneous squamous cell carcinoma, testing innovative drug combinations and targeted approaches.
These studies seek to expand therapeutic options and improve long‑term survival for cancer patients.
The site’s expertise in pain management supports trials targeting chronic peripheral neuropathic pain from post‑herpetic neuralgia and peripheral nerve injury, as well as central neuropathic pain following stroke.
By evaluating new therapies, the centre aims to reduce suffering and restore daily function for individuals with complex pain conditions.
More sites in Boulogne-BillancourtFrance
Clinical trials currently enrolling participants at this site.
Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
FranceA study of MK-1084 and pembrolizumab for patients with resected KRAS G12C-mutant non-small cell lung cancer
FranceStudy of MK-1084 plus durvalumab versus placebo plus durvalumab in patients with locally advanced KRAS G12C‑mutant non‑small cell lung cancer after chemoradiotherapy
FranceAnti‑PD1 Therapy with pembrolizumab and cemiplimab in first‑line advanced non‑small cell lung cancer patients with high PD‑L1 expression
FranceA study of PF-08634404 and a drug combination for adult patients with extensive-stage small cell lung cancer
FranceComparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
FranceA study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer
FranceA study comparing one month versus one year of aspirin and clopidogrel treatment in patients with chronic limb-threatening ischemia after below-the-knee vascular therapy.
FranceA study comparing the effectiveness and safety of datopotamab deruxtecan and docetaxel in adults with advanced or metastatic non-squamous non-small cell lung cancer
FranceStudy of fianlimab plus cemiplimab with chemotherapy or cemiplimab with chemotherapy for patients with pleural mesothelioma who have not received prior treatment
FranceStudy comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer
FranceStudy of trastuzumab deruxtecan with pembrolizumab versus platinum chemotherapy with pembrolizumab for patients with untreated HER2-positive non-small cell lung cancer
FranceMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
